BioCentury | Nov 7, 2020
Targets & Mechanisms

Product profiles that could make interferons effective against COVID-19

...life-threatening COVID-19 cases. Scientists at Imagine Institute, INSERM...
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...function and limits cancer immunotherapy efficacy. An Inserm...
...la Sante et de la Recherche Medicale (INSERM) QIMR...
BioCentury | Jul 29, 2020
Distillery Therapeutics

Promoting degradation of the MDM2 oncogene for liposarcoma

...affiliation as above email: laurent.lecam@inserm.fr Claire Quang Institut National de la Sante et de la Recherche Medicale (INSERM) Mdm2...
BioCentury | Jul 17, 2020
Product Development

Vaccine developments in China include IND acceptance for Fosun, Phase II start for Chongqing Zhifei

...as a potential target for treating severe COVID-19. Assistance Publique - Hopitaux de Paris and INSERM...
...Inc. Assistance Publique - Hopitaux de Paris Institut National de la Sante et de la Recherche Medicale (INSERM) Moleculin...
BioCentury | Jun 30, 2020
Product Development

The U.K.’s push for COVID-19 master protocols pays off again with definitive data on lopinavir-ritonavir

...in active interventional trials for COVID-19, and at least three other master protocols -- REMAP-CAP, INSERM’s...
BioCentury | Jun 2, 2020
Tools & Techniques

Spark’s approach to the problem of redosing AAV gene therapies

...to Gene Therapy 2.0” ). In Nature Medicine Monday, scientists from Spark Therapeutics Inc., Genethon, INSERM...
...efficacy. Sandi Wong, Assistant Editor Spark Therapeutics Inc. Roche Genethon Institut National de la Sante et de la Recherche Medicale (INSERM) Centre...
BioCentury | Jun 2, 2020
Product Development

More data needed to determine best use of remdesivir in COVID-19 patients

...Discovery trial run by the Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...projects focus on COVID-19 treatments. Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | Apr 23, 2020
Product Development

April 22 Quick Takes: Accelerated approval for Immunomedics’ Trodelvy; plus BioNTech-Pfizer, AskBio, Astellas, Merck KGaA, oNKo-Gilead, Myovant, Afyx and Sangam

...gene therapy company BrainVectis, an Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | Apr 16, 2020
Product Development

Master protocols on deck as low enrollment stops Chinese trials of remdesivir

...NIAID), the WHO, and the Institut National de la Sante et de la Recherche Medicale (INSERM...
Items per page:
1 - 10 of 428
BioCentury | Nov 7, 2020
Targets & Mechanisms

Product profiles that could make interferons effective against COVID-19

...life-threatening COVID-19 cases. Scientists at Imagine Institute, INSERM...
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...function and limits cancer immunotherapy efficacy. An Inserm...
...la Sante et de la Recherche Medicale (INSERM) QIMR...
BioCentury | Jul 29, 2020
Distillery Therapeutics

Promoting degradation of the MDM2 oncogene for liposarcoma

...affiliation as above email: laurent.lecam@inserm.fr Claire Quang Institut National de la Sante et de la Recherche Medicale (INSERM) Mdm2...
BioCentury | Jul 17, 2020
Product Development

Vaccine developments in China include IND acceptance for Fosun, Phase II start for Chongqing Zhifei

...as a potential target for treating severe COVID-19. Assistance Publique - Hopitaux de Paris and INSERM...
...Inc. Assistance Publique - Hopitaux de Paris Institut National de la Sante et de la Recherche Medicale (INSERM) Moleculin...
BioCentury | Jun 30, 2020
Product Development

The U.K.’s push for COVID-19 master protocols pays off again with definitive data on lopinavir-ritonavir

...in active interventional trials for COVID-19, and at least three other master protocols -- REMAP-CAP, INSERM’s...
BioCentury | Jun 2, 2020
Tools & Techniques

Spark’s approach to the problem of redosing AAV gene therapies

...to Gene Therapy 2.0” ). In Nature Medicine Monday, scientists from Spark Therapeutics Inc., Genethon, INSERM...
...efficacy. Sandi Wong, Assistant Editor Spark Therapeutics Inc. Roche Genethon Institut National de la Sante et de la Recherche Medicale (INSERM) Centre...
BioCentury | Jun 2, 2020
Product Development

More data needed to determine best use of remdesivir in COVID-19 patients

...Discovery trial run by the Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...projects focus on COVID-19 treatments. Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | Apr 23, 2020
Product Development

April 22 Quick Takes: Accelerated approval for Immunomedics’ Trodelvy; plus BioNTech-Pfizer, AskBio, Astellas, Merck KGaA, oNKo-Gilead, Myovant, Afyx and Sangam

...gene therapy company BrainVectis, an Institut National de la Santé et de la Recherche Médicale (INSERM...
BioCentury | Apr 16, 2020
Product Development

Master protocols on deck as low enrollment stops Chinese trials of remdesivir

...NIAID), the WHO, and the Institut National de la Sante et de la Recherche Medicale (INSERM...
Items per page:
1 - 10 of 428